Home > Medication Guide

Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Related Articles

  • Belzutifan(Welireg)

    Applicable to von Hippel-Lindau (VHL) disease patients requiring treatment for renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastoma, or pancreatic neuroendocri···【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:13

  • Capivasertib(Truqap)

    Capivasertib is suitable for the treatment of adult patients with specific types of breast cancer.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:17

  • Sunitinib(Sutent)

    Sunitinib is a Broad-spectrum antitumor agents.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:5

  • Palbociclib(Ibrance)

    Applicable for the treatment of adult patients with advanced or metastatic breast cancer who are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-···【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:20

  • Ribociclib(Kisqali)

    Ribociclib is a Broad-spectrum antitumor agents.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:7

  • Anagrelide(Agrylin)

    Thrombocythemia【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:5

  • Binimetinib(Mektovi)

    Binimetinib can be used for the treatment of melanoma and non-small cell lung cancer.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:0

  • Elacestrant(Orserdu)

    Elacestrant is suitable for the treatment of specific types of breast cancer.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:16

  • Resmetirom(Rezdiffra)

    Non-cirrhosis non-alcoholic steatohepatitis【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:4

  • Futibatinib(Lytgobi)

    Carcinoma of bile duct【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:15

  • Tazemetostat(Tazverik)

    Tazemetostat is a Broad-spectrum antitumor agents.【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:6

  • Abemaciclib(Verzenios)

    Indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage, late-stage, or metastatic breast cancer in adul···【more】
    Article source:Captain MedicineRelease date:2026-01-05Recommended:0

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

WhatsApp